“…Some authors expand this spectrum of clinical signs by two less frequent symptoms, that is, (8) congenital cardiac defects (particularly in the Asian population; Fabre et al, 2012, 2013, 2014, 2017; W. I. Lee et al, 2016); and (9) platelet abnormalities (Fabre et al, 2012, 2013, 2014, 2017; Hartley et al, 2010). Other anomalies detected in THES patients include: enteric symptoms (colitis, intestinal villous atrophy; abnormal sorting and/or decreased expression of several brush‐border transport proteins, such as: Na + /H + exchangers, aquaporin 7, Na + /I − symporter and the H + /K + ATPase, on the apical surface of jejunal enterocytes, was demonstrated by immunohistochemistry; Hartley et al, 2010), hypoglycemia (Gao et al, 2022; Xinias et al, 2018), dental abnormalities (Karaca Edeer et al, 2019), premature birth with low birth weight (Fabre et al, 2012; Fabre et al, 2013), short stature (below third percentile in 50% of individuals; Fabre et al, 2014; M. Yang, Jiang, et al, 2022), and mild mental retardation (Fabre et al, 2014). Due to such a wide spectrum of symptoms, the prognosis is poor and one of THES characteristics is high mortality rate (up to 50%)—many patients die before the age of 5–10 and just a few affected individuals survived up to the third decade (Fabre et al, 2014).…”